Trump Signs Order Fast-Tracking Psychedelic Drug Review; Eases FDA Restrictions
President Trump signed an executive order to expedite FDA review and access to psychedelic drugs like ibogaine, which veteran groups advocate for PTSD treatment, with podcaster Joe Rogan joining the signing event.